Our results are in line with other, albeit small, studies that have also reported a link between haemoglobin levels and impaired survival in HCC patients treated with PD-1 inhibitors,17 Yttrium-90 radioembolisation18 and various first-line treatments.15 This evidence concerns the gene PDCD1 and hepatocellular carcinoma.